239 related articles for article (PubMed ID: 30619764)
1. Predicting Gleason Score of Prostate Cancer Patients Using Radiomic Analysis.
Chaddad A; Niazi T; Probst S; Bladou F; Anidjar M; Bahoric B
Front Oncol; 2018; 8():630. PubMed ID: 30619764
[No Abstract] [Full Text] [Related]
2. Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer.
Chaddad A; Kucharczyk MJ; Niazi T
Cancers (Basel); 2018 Jul; 10(8):. PubMed ID: 30060575
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Clinically Significant Cancer Using Radiomics Features of Pre-Biopsy of Multiparametric MRI in Men Suspected of Prostate Cancer.
Ogbonnaya CN; Zhang X; Alsaedi BSO; Pratt N; Zhang Y; Johnston L; Nabi G
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944819
[TBL] [Abstract][Full Text] [Related]
4. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
[TBL] [Abstract][Full Text] [Related]
5. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Prediction of High-Grade Prostate Cancer via Biparametric MRI Radiomics.
Gong L; Xu M; Fang M; Zou J; Yang S; Yu X; Xu D; Zhou L; Li H; He B; Wang Y; Fang X; Dong D; Tian J
J Magn Reson Imaging; 2020 Oct; 52(4):1102-1109. PubMed ID: 32212356
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
[TBL] [Abstract][Full Text] [Related]
8. Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: preliminary findings.
Midya A; Hiremath A; Huber J; Sankar Viswanathan V; Omil-Lima D; Mahran A; Bittencourt LK; Harsha Tirumani S; Ponsky L; Shiradkar R; Madabhushi A
Front Oncol; 2023; 13():1166047. PubMed ID: 37731630
[TBL] [Abstract][Full Text] [Related]
9. Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness.
Damascelli A; Gallivanone F; Cristel G; Cava C; Interlenghi M; Esposito A; Brembilla G; Briganti A; Montorsi F; Castiglioni I; De Cobelli F
Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33810222
[TBL] [Abstract][Full Text] [Related]
10. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Gleason score in prostate cancer patients based on radiomic features of transrectal ultrasound images.
Cheng T; Li H
Br J Radiol; 2024 Feb; 97(1154):415-421. PubMed ID: 38308030
[TBL] [Abstract][Full Text] [Related]
12. MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
Gugliandolo SG; Pepa M; Isaksson LJ; Marvaso G; Raimondi S; Botta F; Gandini S; Ciardo D; Volpe S; Riva G; Rojas DP; Zerini D; Pricolo P; Alessi S; Petralia G; Summers PE; Mistretta FA; Luzzago S; Cattani F; De Cobelli O; Cassano E; Cremonesi M; Bellomi M; Orecchia R; Jereczek-Fossa BA
Eur Radiol; 2021 Feb; 31(2):716-728. PubMed ID: 32852590
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging radiomic feature analysis of radiation-induced femoral head changes in prostate cancer radiotherapy.
Abdollahi H; Mahdavi SR; Shiri I; Mofid B; Bakhshandeh M; Rahmani K
J Cancer Res Ther; 2019 Mar; 15(Supplement):S11-S19. PubMed ID: 30900614
[TBL] [Abstract][Full Text] [Related]
14. Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study.
Algohary A; Shiradkar R; Pahwa S; Purysko A; Verma S; Moses D; Shnier R; Haynes AM; Delprado W; Thompson J; Tirumani S; Mahran A; Rastinehad AR; Ponsky L; Stricker PD; Madabhushi A
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32781640
[No Abstract] [Full Text] [Related]
15. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
[TBL] [Abstract][Full Text] [Related]
16. Utility of radiomic zones for risk classification and clinical outcome predictions using supervised machine learning during simultaneous
Tu SJ; Tran VT; Teo JM; Chong WC; Tseng JR
Med Phys; 2021 Sep; 48(9):5192-5201. PubMed ID: 34214211
[TBL] [Abstract][Full Text] [Related]
17. Development of a Novel, Multi-Parametric, MRI-Based Radiomic Nomogram for Differentiating Between Clinically Significant and Insignificant Prostate Cancer.
Zhang Y; Chen W; Yue X; Shen J; Gao C; Pang P; Cui F; Xu M
Front Oncol; 2020; 10():888. PubMed ID: 32695660
[No Abstract] [Full Text] [Related]
18. A radiomics approach based on MR imaging for classification of deficiency and excess syndrome of traditional Chinese medicine in prostate cancer.
Zhang Y; Yang H; Li Z; Gao C; Chen Y; Huang Y; Yue X; Shu C; Wei Y; Cui F; Xu M
Heliyon; 2023 Dec; 9(12):e23242. PubMed ID: 38144279
[TBL] [Abstract][Full Text] [Related]
19. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.
Ma XZ; Lv K; Sheng JL; Yu YX; Pang PP; Xu MS; Wang SW
Oncol Lett; 2019 Mar; 17(3):3077-3084. PubMed ID: 30867737
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
